BIOMAT Database Logo BIOMAT Database Logo

Use of Uridine Triacetate to Reverse Severe Persistent Myelosuppression Following 5-fluorouracil Exposure in a Patient With a c.557A>G Heterozygous DPYD Variant. 2021

Michael Leung, and Jane E Rogers, and Imad Shureiqi
Department of Pharmacy Clinical Programs, The University of Texas MD Anderson Cancer Center, Houston, TX.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000085 Acetates Derivatives of ACETIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxymethane structure. Acetate,Acetic Acid Esters,Acetic Acids,Acids, Acetic,Esters, Acetic Acid
D014529 Uridine A ribonucleoside in which RIBOSE is linked to URACIL. Allo-Uridine,Allouridine,Allo Uridine

Related Publications

Michael Leung, and Jane E Rogers, and Imad Shureiqi
Benefit of uridine triacetate (Vistogard) in rescuing severe 5-fluorouracil toxicity in patients with dihydropyrimidine dehydrogenase (DPYD) deficiency.
July 2016, Cancer chemotherapy and pharmacology,
Michael Leung, and Jane E Rogers, and Imad Shureiqi
Uridine triacetate for severe 5-fluorouracil toxicity in a patient with thymidylate synthase gene variation: Potential pharmacogenomic implications.
January 2018, SAGE open medical case reports,
Michael Leung, and Jane E Rogers, and Imad Shureiqi
Dose modification for safe treatment of a compound complex heterozygous DPYD variant carrier with 5-fluorouracil.
January 2018, JCO precision oncology,
Michael Leung, and Jane E Rogers, and Imad Shureiqi
The successful treatment of 5-fluorouracil (5-FU) overdose in a patient with malignancy and HIV/AIDS with uridine triacetate.
May 2017, The American journal of emergency medicine,
Michael Leung, and Jane E Rogers, and Imad Shureiqi
Use of uridine triacetate for the management of fluorouracil overdose.
October 2011, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
Michael Leung, and Jane E Rogers, and Imad Shureiqi
Early-Onset 5-Fluorouracil Toxicity in a Patient Negative for Dihydropyrimidine Dehydrogenase Mutations: The Clinical Course of Reversal with Uridine Triacetate.
November 2016, Pharmacotherapy,
Michael Leung, and Jane E Rogers, and Imad Shureiqi
Uridine Triacetate for Severe Fluoropyrimidine Cardiotoxicity in a Patient With Thymidylate Synthase Gene Variants.
June 2020, JACC. CardioOncology,
Michael Leung, and Jane E Rogers, and Imad Shureiqi
Reversal of 5-fluorouracil-induced myelosuppression by prolonged administration of high-dose uridine.
January 1989, Journal of the National Cancer Institute,
Michael Leung, and Jane E Rogers, and Imad Shureiqi
Emergency use of uridine triacetate for the prevention and treatment of life-threatening 5-fluorouracil and capecitabine toxicity.
January 2017, Cancer,
Michael Leung, and Jane E Rogers, and Imad Shureiqi
Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance).
March 2016, Pharmacogenetics and genomics,
Copied contents to your clipboard!